article thumbnail

Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox

BioPharma Reporter

Ajinomoto Bio-Pharma Services and Revance Therapeutics have announced a strategic commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.

Botox 52
article thumbnail

Latest ABPI code breaches reveal the risk of ‘likes’ on LinkedIn

pharmaphorum

Allergan fell foul of the regulations for a number of LinkedIn and Instagram posts promoting Botox (botulinum toxin type A) to the public by the chief executive of aesthetics clinic – described in his profile as an ‘Allergan mentee’, which were also liked or commented on by employees of the company.

Botox 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ireland is open: The biologics boom boosting the Irish economy

pharmaphorum

In 2020, Allergan opened a global Botox manufacturing facility in Westport, a tourist town on the west coast of Ireland and biotech company Regeneron established a biologic plant in Limerick.

article thumbnail

AbbVie adds to neuroscience pipeline with $1bn Syndesi buy

pharmaphorum

SV2A is an emerging target in neurological diseases, a poorly understood transmembrane glycoprotein that is thought to play a role in regulating the release of neurotransmitter molecules from neurons.

Botox 52
article thumbnail

AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results

The Pharma Data

– Full-Year Global Net Revenues from the Aesthetics Portfolio Were $2.590 Billion; Global Botox Cosmetic Net Revenues Were $1.112 Billion. – Full-Year Global Net Revenues from the Neuroscience Portfolio Were $3.496 Billion; Global Botox Therapeutic Net Revenues Were $1.387 Billion; Global Vraylar Net Revenues Were $951 Million.

Botox 52
article thumbnail

AbbVie Reports First-Quarter 2021 Financial Results

The Pharma Data

Global Botox Cosmetic net revenues were $477 million , an increase of 44.7 Global Botox Therapeutic net revenues were $532 million , an increase of 7.0 Botox Cosmetic*. Botox Therapeutic*. Global net revenues from the aesthetics portfolio were $1.141 billion , an increase of 34.9 percent on a comparable operational basis.

Botox 40
article thumbnail

World Cerebral Palsy Day 2024: Uniquely CP

XTalks

Botulinum toxin (Botox) injections can temporarily reduce muscle spasticity by tightening muscles in specific areas. Advocate for Change: Reach out to policymakers and advocate for laws and regulations that support the rights of individuals with cerebral palsy. Muscle relaxants (e.g.,